Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Cancer Res. 2018 Aug 9;78(19):5513–5520. doi: 10.1158/0008-5472.CAN-17-3912

Figure 3. Loss of MST in PAX3-FOXO1-aRMS inhibits non-canonical Hippo signaling.

Figure 3.

(A) IHC of tumors from MSTWT and MSTNull mice both show strong nuclear YAP1 staining, suggesting that loss of MST1 and MST2 in the MSTNull group is not impacting canonical Hippo signaling, in accord with the immunoblot of Hippo pathway proteins shown in Fig.2A. Representative images shown. (B) Immunofluorescence of tumor-derived cell lines from both MSTWT and MSTNull groups show strong nuclear YAP1 staining. Scale bar: 50µm. (C) Immunoblots of fractionated cell lysates of tumor-derived cell lines show YAP1 in the nuclear but not cytoplasmic fraction, independent of cell density.